However, data on their effect on tumor growth and modulation of the tumor microenvironment (TME) are still controversial, most likely due to the cell-type-specific, activation-dependent, and multi-facetted role of β2 integrins and especially MAC-1. The gene discussed is ITGB2; the disease is neoplasm.